nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7—Irinotecan—colon cancer	0.112	0.175	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.112	0.175	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0979	0.153	CbGbCtD
Fluticasone Propionate—CYP3A7—Vincristine—colon cancer	0.0979	0.153	CbGbCtD
Fluticasone Propionate—CYP3A5—Irinotecan—colon cancer	0.084	0.132	CbGbCtD
Fluticasone Propionate—CYP3A5—Vincristine—colon cancer	0.0734	0.115	CbGbCtD
Fluticasone Propionate—CYP3A4—Irinotecan—colon cancer	0.0328	0.0513	CbGbCtD
Fluticasone Propionate—CYP3A4—Vincristine—colon cancer	0.0286	0.0448	CbGbCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—colon cancer	0.00768	1	CbGdCrCtD
Fluticasone Propionate—PGR—blood vessel—colon cancer	0.00446	0.075	CbGeAlD
Fluticasone Propionate—Scab—Capecitabine—colon cancer	0.00358	0.0154	CcSEcCtD
Fluticasone Propionate—Lower respiratory tract infection—Capecitabine—colon cancer	0.00333	0.0143	CcSEcCtD
Fluticasone Propionate—Bronchial hyperreactivity—Methotrexate—colon cancer	0.00324	0.0139	CcSEcCtD
Fluticasone Propionate—Chronic obstructive pulmonary disease—Methotrexate—colon cancer	0.00296	0.0127	CcSEcCtD
Fluticasone Propionate—Lacrimation—Irinotecan—colon cancer	0.00289	0.0124	CcSEcCtD
Fluticasone Propionate—Lacrimation—Fluorouracil—colon cancer	0.00277	0.0119	CcSEcCtD
Fluticasone Propionate—PLA2G4A—smooth muscle tissue—colon cancer	0.00276	0.0466	CbGeAlD
Fluticasone Propionate—PLA2G4A—renal system—colon cancer	0.00266	0.0448	CbGeAlD
Fluticasone Propionate—SERPINA6—renal system—colon cancer	0.00265	0.0446	CbGeAlD
Fluticasone Propionate—Hoarseness—Capecitabine—colon cancer	0.00259	0.0111	CcSEcCtD
Fluticasone Propionate—Blister—Fluorouracil—colon cancer	0.00226	0.0097	CcSEcCtD
Fluticasone Propionate—NR3C2—smooth muscle tissue—colon cancer	0.00225	0.0379	CbGeAlD
Fluticasone Propionate—PGR—epithelium—colon cancer	0.00217	0.0365	CbGeAlD
Fluticasone Propionate—NR3C2—renal system—colon cancer	0.00216	0.0364	CbGeAlD
Fluticasone Propionate—PGR—smooth muscle tissue—colon cancer	0.00209	0.0352	CbGeAlD
Fluticasone Propionate—Sneezing—Capecitabine—colon cancer	0.00205	0.00882	CcSEcCtD
Fluticasone Propionate—CYP3A7—liver—colon cancer	0.00203	0.0342	CbGeAlD
Fluticasone Propionate—PLA2G4A—bone marrow—colon cancer	0.00201	0.0339	CbGeAlD
Fluticasone Propionate—Stinging—Fluorouracil—colon cancer	0.00201	0.00863	CcSEcCtD
Fluticasone Propionate—SERPINA6—bone marrow—colon cancer	0.002	0.0337	CbGeAlD
Fluticasone Propionate—Leukoderma—Methotrexate—colon cancer	0.00199	0.00856	CcSEcCtD
Fluticasone Propionate—PLA2G4A—vagina—colon cancer	0.00193	0.0325	CbGeAlD
Fluticasone Propionate—Eye irritation—Fluorouracil—colon cancer	0.00191	0.00819	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Irinotecan—colon cancer	0.00184	0.00792	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Capecitabine—colon cancer	0.00179	0.00769	CcSEcCtD
Fluticasone Propionate—NR3C2—digestive system—colon cancer	0.00178	0.0299	CbGeAlD
Fluticasone Propionate—Herpes simplex—Fluorouracil—colon cancer	0.00177	0.00759	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Fluorouracil—colon cancer	0.00177	0.00759	CcSEcCtD
Fluticasone Propionate—Supraventricular tachycardia—Capecitabine—colon cancer	0.00174	0.00746	CcSEcCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—liver—colon cancer	0.00173	0.0291	CbGeAlD
Fluticasone Propionate—PGR—lymphoid tissue—colon cancer	0.00167	0.0281	CbGeAlD
Fluticasone Propionate—SERPINA6—liver—colon cancer	0.00162	0.0273	CbGeAlD
Fluticasone Propionate—Dermatitis contact—Fluorouracil—colon cancer	0.00161	0.00691	CcSEcCtD
Fluticasone Propionate—Throat sore—Capecitabine—colon cancer	0.00158	0.00678	CcSEcCtD
Fluticasone Propionate—Blister—Capecitabine—colon cancer	0.00158	0.00678	CcSEcCtD
Fluticasone Propionate—NR3C2—vagina—colon cancer	0.00157	0.0264	CbGeAlD
Fluticasone Propionate—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00156	0.00672	CcSEcCtD
Fluticasone Propionate—NR3C1—embryo—colon cancer	0.00153	0.0258	CbGeAlD
Fluticasone Propionate—Osteoporosis—Methotrexate—colon cancer	0.00151	0.00649	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Capecitabine—colon cancer	0.00149	0.00638	CcSEcCtD
Fluticasone Propionate—Fracture—Methotrexate—colon cancer	0.00146	0.00626	CcSEcCtD
Fluticasone Propionate—Multiple fractures—Methotrexate—colon cancer	0.00146	0.00626	CcSEcCtD
Fluticasone Propionate—PGR—vagina—colon cancer	0.00146	0.0245	CbGeAlD
Fluticasone Propionate—Rhinorrhoea—Capecitabine—colon cancer	0.0014	0.00603	CcSEcCtD
Fluticasone Propionate—Ageusia—Capecitabine—colon cancer	0.0014	0.00603	CcSEcCtD
Fluticasone Propionate—Dysphonia—Capecitabine—colon cancer	0.00138	0.00594	CcSEcCtD
Fluticasone Propionate—Extrasystoles—Capecitabine—colon cancer	0.00135	0.00581	CcSEcCtD
Fluticasone Propionate—Folliculitis—Methotrexate—colon cancer	0.00135	0.00579	CcSEcCtD
Fluticasone Propionate—Psoriasis—Methotrexate—colon cancer	0.00135	0.00579	CcSEcCtD
Fluticasone Propionate—Eye irritation—Capecitabine—colon cancer	0.00133	0.00572	CcSEcCtD
Fluticasone Propionate—NR3C2—liver—colon cancer	0.00132	0.0223	CbGeAlD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—TGFB1—colon cancer	0.00132	0.0224	CbGpPWpGaD
Fluticasone Propionate—Contusion—Capecitabine—colon cancer	0.0013	0.0056	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Irinotecan—colon cancer	0.00127	0.00547	CcSEcCtD
Fluticasone Propionate—NR3C1—epithelium—colon cancer	0.00125	0.0211	CbGeAlD
Fluticasone Propionate—Oropharyngeal pain—Capecitabine—colon cancer	0.00125	0.00537	CcSEcCtD
Fluticasone Propionate—PLA2G4A—lymph node—colon cancer	0.00125	0.021	CbGeAlD
Fluticasone Propionate—Dermatitis bullous—Fluorouracil—colon cancer	0.00124	0.00531	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Capecitabine—colon cancer	0.00123	0.0053	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Capecitabine—colon cancer	0.00123	0.0053	CcSEcCtD
Fluticasone Propionate—NR3C1—smooth muscle tissue—colon cancer	0.00121	0.0203	CbGeAlD
Fluticasone Propionate—Cataract—Capecitabine—colon cancer	0.0012	0.00513	CcSEcCtD
Fluticasone Propionate—CYP3A5—renal system—colon cancer	0.00117	0.0197	CbGeAlD
Fluticasone Propionate—NR3C1—renal system—colon cancer	0.00116	0.0195	CbGeAlD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PTPRJ—colon cancer	0.00115	0.0196	CbGpPWpGaD
Fluticasone Propionate—Irritability—Fluorouracil—colon cancer	0.00113	0.00484	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Irinotecan—colon cancer	0.00111	0.00477	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Capecitabine—colon cancer	0.0011	0.00474	CcSEcCtD
Fluticasone Propionate—Candida infection—Capecitabine—colon cancer	0.00109	0.00466	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Irinotecan—colon cancer	0.00107	0.00461	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CHST4—colon cancer	0.00106	0.0181	CbGpPWpGaD
Fluticasone Propionate—Nasopharyngitis—Fluorouracil—colon cancer	0.00106	0.00454	CcSEcCtD
Fluticasone Propionate—NR3C2—lymph node—colon cancer	0.00101	0.0171	CbGeAlD
Fluticasone Propionate—Upper respiratory tract infection—Irinotecan—colon cancer	0.000991	0.00426	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptors—HNF4A—colon cancer	0.000986	0.0168	CbGpPWpGaD
Fluticasone Propionate—Pneumonia—Vincristine—colon cancer	0.000982	0.00422	CcSEcCtD
Fluticasone Propionate—NR3C1—lymphoid tissue—colon cancer	0.000964	0.0162	CbGeAlD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000961	0.0164	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—digestive system—colon cancer	0.00096	0.0162	CbGeAlD
Fluticasone Propionate—Pneumonia—Irinotecan—colon cancer	0.000956	0.00411	CcSEcCtD
Fluticasone Propionate—Sleep disorder—Capecitabine—colon cancer	0.000954	0.0041	CcSEcCtD
Fluticasone Propionate—NR3C1—digestive system—colon cancer	0.000952	0.016	CbGeAlD
Fluticasone Propionate—Diabetes mellitus—Capecitabine—colon cancer	0.000949	0.00408	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000949	0.00408	CcSEcCtD
Fluticasone Propionate—PGR—lymph node—colon cancer	0.000942	0.0159	CbGeAlD
Fluticasone Propionate—Herpes simplex—Methotrexate—colon cancer	0.000919	0.00395	CcSEcCtD
Fluticasone Propionate—Pneumonia—Fluorouracil—colon cancer	0.000916	0.00393	CcSEcCtD
Fluticasone Propionate—Infestation—Fluorouracil—colon cancer	0.000911	0.00391	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Fluorouracil—colon cancer	0.000911	0.00391	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Fluorouracil—colon cancer	0.000885	0.0038	CcSEcCtD
Fluticasone Propionate—CYP3A4—renal system—colon cancer	0.000878	0.0148	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—colon cancer	0.000878	0.0148	CbGeAlD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.000877	0.0149	CbGpPWpGaD
Fluticasone Propionate—Hypoaesthesia—Vincristine—colon cancer	0.000872	0.00375	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Capecitabine—colon cancer	0.000871	0.00374	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Capecitabine—colon cancer	0.000864	0.00371	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Vincristine—colon cancer	0.000861	0.0037	CcSEcCtD
Fluticasone Propionate—Epistaxis—Fluorouracil—colon cancer	0.000859	0.00369	CcSEcCtD
Fluticasone Propionate—Sinusitis—Fluorouracil—colon cancer	0.000854	0.00367	CcSEcCtD
Fluticasone Propionate—CYP3A5—vagina—colon cancer	0.000847	0.0143	CbGeAlD
Fluticasone Propionate—NR3C1—vagina—colon cancer	0.000841	0.0142	CbGeAlD
Fluticasone Propionate—Connective tissue disorder—Irinotecan—colon cancer	0.000839	0.0036	CcSEcCtD
Fluticasone Propionate—NR3C2—Preimplantation Embryo—CDH1—colon cancer	0.000827	0.0141	CbGpPWpGaD
Fluticasone Propionate—Cardiac disorder—Vincristine—colon cancer	0.000813	0.00349	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Fluorouracil—colon cancer	0.000813	0.00349	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Fluorouracil—colon cancer	0.000811	0.00348	CcSEcCtD
Fluticasone Propionate—Face oedema—Capecitabine—colon cancer	0.000797	0.00342	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Irinotecan—colon cancer	0.000792	0.0034	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Vincristine—colon cancer	0.00079	0.00339	CcSEcCtD
Fluticasone Propionate—Irritability—Capecitabine—colon cancer	0.000788	0.00338	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.000779	0.0133	CbGpPWpGaD
Fluticasone Propionate—Immune system disorder—Irinotecan—colon cancer	0.000771	0.00331	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Irinotecan—colon cancer	0.000769	0.0033	CcSEcCtD
Fluticasone Propionate—Mental disorder—Vincristine—colon cancer	0.000768	0.0033	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Irinotecan—colon cancer	0.000763	0.00327	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptors—PPARG—colon cancer	0.000741	0.0126	CbGpPWpGaD
Fluticasone Propionate—Nasopharyngitis—Capecitabine—colon cancer	0.000738	0.00317	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Fluorouracil—colon cancer	0.00073	0.00314	CcSEcCtD
Fluticasone Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—colon cancer	0.000726	0.0124	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—digestive system—colon cancer	0.00072	0.0121	CbGeAlD
Fluticasone Propionate—Abdominal distension—Capecitabine—colon cancer	0.000719	0.00309	CcSEcCtD
Fluticasone Propionate—CYP3A5—liver—colon cancer	0.000715	0.012	CbGeAlD
Fluticasone Propionate—Muscle spasms—Irinotecan—colon cancer	0.000714	0.00307	CcSEcCtD
Fluticasone Propionate—Asthma—Capecitabine—colon cancer	0.000714	0.00307	CcSEcCtD
Fluticasone Propionate—Erythema—Fluorouracil—colon cancer	0.000712	0.00306	CcSEcCtD
Fluticasone Propionate—NR3C1—liver—colon cancer	0.000709	0.0119	CbGeAlD
Fluticasone Propionate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000708	0.0121	CbGpPWpGaD
Fluticasone Propionate—Diabetes mellitus—Methotrexate—colon cancer	0.000707	0.00304	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Capecitabine—colon cancer	0.000702	0.00302	CcSEcCtD
Fluticasone Propionate—CYP3A5—Irinotecan Pathway—APC—colon cancer	0.000702	0.012	CbGpPWpGaD
Fluticasone Propionate—Agitation—Vincristine—colon cancer	0.000701	0.00301	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Irinotecan—colon cancer	0.000689	0.00296	CcSEcCtD
Fluticasone Propionate—Bronchitis—Capecitabine—colon cancer	0.000686	0.00295	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Capecitabine—colon cancer	0.000684	0.00294	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CHST5—colon cancer	0.000676	0.0115	CbGpPWpGaD
Fluticasone Propionate—Vision blurred—Fluorouracil—colon cancer	0.000671	0.00288	CcSEcCtD
Fluticasone Propionate—Malaise—Irinotecan—colon cancer	0.00067	0.00288	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000667	0.0114	CbGpPWpGaD
Fluticasone Propionate—Upper respiratory tract infection—Capecitabine—colon cancer	0.000663	0.00285	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.000663	0.0113	CbGpPWpGaD
Fluticasone Propionate—Hypertension—Vincristine—colon cancer	0.000659	0.00283	CcSEcCtD
Fluticasone Propionate—Cough—Irinotecan—colon cancer	0.000648	0.00278	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Capecitabine—colon cancer	0.000644	0.00276	CcSEcCtD
Fluticasone Propionate—Hypertension—Irinotecan—colon cancer	0.000642	0.00276	CcSEcCtD
Fluticasone Propionate—Pneumonia—Capecitabine—colon cancer	0.00064	0.00275	CcSEcCtD
Fluticasone Propionate—Infestation—Capecitabine—colon cancer	0.000636	0.00273	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Capecitabine—colon cancer	0.000636	0.00273	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Methotrexate—colon cancer	0.000635	0.00273	CcSEcCtD
Fluticasone Propionate—Discomfort—Irinotecan—colon cancer	0.000625	0.00268	CcSEcCtD
Fluticasone Propionate—Oedema—Vincristine—colon cancer	0.000623	0.00267	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Vincristine—colon cancer	0.000623	0.00267	CcSEcCtD
Fluticasone Propionate—Infection—Vincristine—colon cancer	0.000619	0.00266	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Capecitabine—colon cancer	0.000619	0.00266	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Vincristine—colon cancer	0.000611	0.00262	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Irinotecan—colon cancer	0.000606	0.0026	CcSEcCtD
Fluticasone Propionate—Oedema—Irinotecan—colon cancer	0.000606	0.0026	CcSEcCtD
Fluticasone Propionate—Chest pain—Fluorouracil—colon cancer	0.000606	0.0026	CcSEcCtD
Fluticasone Propionate—Infection—Irinotecan—colon cancer	0.000602	0.00259	CcSEcCtD
Fluticasone Propionate—Epistaxis—Capecitabine—colon cancer	0.0006	0.00258	CcSEcCtD
Fluticasone Propionate—Fluticasone furoate—ABCB1—colon cancer	0.000599	0.223	CrCbGaD
Fluticasone Propionate—Discomfort—Fluorouracil—colon cancer	0.000599	0.00257	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Irinotecan—colon cancer	0.000595	0.00255	CcSEcCtD
Fluticasone Propionate—Irritability—Methotrexate—colon cancer	0.000587	0.00252	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000585	0.00998	CbGpPWpGaD
Fluticasone Propionate—Oedema—Fluorouracil—colon cancer	0.000581	0.00249	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Fluorouracil—colon cancer	0.000581	0.00249	CcSEcCtD
Fluticasone Propionate—Infection—Fluorouracil—colon cancer	0.000577	0.00248	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	0.000575	0.0098	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Fluorouracil—colon cancer	0.00057	0.00245	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Capecitabine—colon cancer	0.000568	0.00244	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000567	0.00244	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Capecitabine—colon cancer	0.000567	0.00244	CcSEcCtD
Fluticasone Propionate—Tachycardia—Fluorouracil—colon cancer	0.000567	0.00243	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Capecitabine—colon cancer	0.000561	0.00241	CcSEcCtD
Fluticasone Propionate—NR3C1—lymph node—colon cancer	0.000544	0.00916	CbGeAlD
Fluticasone Propionate—Dyspnoea—Irinotecan—colon cancer	0.000541	0.00232	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.000538	0.00917	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—ADP signalling through P2Y purinoceptor 1—SRC—colon cancer	0.000538	0.00917	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—liver—colon cancer	0.000536	0.00903	CbGeAlD
Fluticasone Propionate—Eye disorder—Capecitabine—colon cancer	0.000534	0.00229	CcSEcCtD
Fluticasone Propionate—Pain—Vincristine—colon cancer	0.000532	0.00229	CcSEcCtD
Fluticasone Propionate—Asthma—Methotrexate—colon cancer	0.000531	0.00228	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Capecitabine—colon cancer	0.00053	0.00228	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000529	0.00227	CcSEcCtD
Fluticasone Propionate—Pain—Irinotecan—colon cancer	0.000519	0.00223	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Fluorouracil—colon cancer	0.000518	0.00222	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Capecitabine—colon cancer	0.000516	0.00222	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Capecitabine—colon cancer	0.000515	0.00221	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Capecitabine—colon cancer	0.00051	0.00219	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Methotrexate—colon cancer	0.000509	0.00219	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Vincristine—colon cancer	0.000509	0.00219	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—colon cancer	0.000508	0.00866	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000503	0.00857	CbGpPWpGaD
Fluticasone Propionate—Mental disorder—Capecitabine—colon cancer	0.0005	0.00215	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Irinotecan—colon cancer	0.0005	0.00215	CcSEcCtD
Fluticasone Propionate—Erythema—Capecitabine—colon cancer	0.000497	0.00214	CcSEcCtD
Fluticasone Propionate—Malnutrition—Capecitabine—colon cancer	0.000497	0.00214	CcSEcCtD
Fluticasone Propionate—Pain—Fluorouracil—colon cancer	0.000497	0.00213	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Irinotecan—colon cancer	0.000496	0.00213	CcSEcCtD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000495	0.00843	CbGpPWpGaD
Fluticasone Propionate—Upper respiratory tract infection—Methotrexate—colon cancer	0.000494	0.00212	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Vincristine—colon cancer	0.000492	0.00211	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Vincristine—colon cancer	0.000492	0.00211	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CHST5—colon cancer	0.000489	0.00833	CbGpPWpGaD
Fluticasone Propionate—Abdominal pain—Irinotecan—colon cancer	0.000479	0.00206	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Irinotecan—colon cancer	0.000479	0.00206	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Fluorouracil—colon cancer	0.000479	0.00206	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Capecitabine—colon cancer	0.000478	0.00205	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—ABCB1—colon cancer	0.000478	0.178	CrCbGaD
Fluticasone Propionate—Pneumonia—Methotrexate—colon cancer	0.000476	0.00205	CcSEcCtD
Fluticasone Propionate—Triamcinolone—PTGS2—colon cancer	0.000474	0.176	CrCbGaD
Fluticasone Propionate—Infestation NOS—Methotrexate—colon cancer	0.000474	0.00203	CcSEcCtD
Fluticasone Propionate—Infestation—Methotrexate—colon cancer	0.000474	0.00203	CcSEcCtD
Fluticasone Propionate—Vision blurred—Capecitabine—colon cancer	0.000469	0.00201	CcSEcCtD
Fluticasone Propionate—Tremor—Capecitabine—colon cancer	0.000466	0.002	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Capecitabine—colon cancer	0.000461	0.00198	CcSEcCtD
Fluticasone Propionate—Urticaria—Fluorouracil—colon cancer	0.000461	0.00198	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Methotrexate—colon cancer	0.00046	0.00198	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Fluorouracil—colon cancer	0.000459	0.00197	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Vincristine—colon cancer	0.000459	0.00197	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000455	0.00775	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signal amplification—SRC—colon cancer	0.000453	0.00772	CbGpPWpGaD
Fluticasone Propionate—Malaise—Capecitabine—colon cancer	0.000448	0.00193	CcSEcCtD
Fluticasone Propionate—Epistaxis—Methotrexate—colon cancer	0.000447	0.00192	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Irinotecan—colon cancer	0.000447	0.00192	CcSEcCtD
Fluticasone Propionate—Palpitations—Capecitabine—colon cancer	0.000439	0.00189	CcSEcCtD
Fluticasone Propionate—Cough—Capecitabine—colon cancer	0.000434	0.00186	CcSEcCtD
Fluticasone Propionate—Hypertension—Capecitabine—colon cancer	0.000429	0.00184	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptors—PPARG—colon cancer	0.000428	0.0073	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Fluorouracil—colon cancer	0.000428	0.00184	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vincristine—colon cancer	0.000426	0.00183	CcSEcCtD
Fluticasone Propionate—Chest pain—Capecitabine—colon cancer	0.000423	0.00182	CcSEcCtD
Fluticasone Propionate—Arthralgia—Capecitabine—colon cancer	0.000423	0.00182	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—colon cancer	0.000422	0.00181	CcSEcCtD
Fluticasone Propionate—Anxiety—Capecitabine—colon cancer	0.000422	0.00181	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00042	0.00181	CcSEcCtD
Fluticasone Propionate—Discomfort—Capecitabine—colon cancer	0.000418	0.0018	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Irinotecan—colon cancer	0.000415	0.00178	CcSEcCtD
Fluticasone Propionate—Dry mouth—Capecitabine—colon cancer	0.000414	0.00178	CcSEcCtD
Fluticasone Propionate—Dizziness—Vincristine—colon cancer	0.000412	0.00177	CcSEcCtD
Fluticasone Propionate—Pruritus—Fluorouracil—colon cancer	0.000411	0.00176	CcSEcCtD
Fluticasone Propionate—Oedema—Capecitabine—colon cancer	0.000406	0.00174	CcSEcCtD
Fluticasone Propionate—Infection—Capecitabine—colon cancer	0.000403	0.00173	CcSEcCtD
Fluticasone Propionate—Dizziness—Irinotecan—colon cancer	0.000401	0.00172	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Capecitabine—colon cancer	0.000398	0.00171	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—colon cancer	0.000397	0.00171	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Fluorouracil—colon cancer	0.000397	0.00171	CcSEcCtD
Fluticasone Propionate—Tachycardia—Capecitabine—colon cancer	0.000396	0.0017	CcSEcCtD
Fluticasone Propionate—Vomiting—Vincristine—colon cancer	0.000396	0.0017	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—colon cancer	0.000395	0.0017	CcSEcCtD
Fluticasone Propionate—Skin disorder—Capecitabine—colon cancer	0.000394	0.00169	CcSEcCtD
Fluticasone Propionate—Rash—Vincristine—colon cancer	0.000393	0.00169	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vincristine—colon cancer	0.000392	0.00168	CcSEcCtD
Fluticasone Propionate—Headache—Vincristine—colon cancer	0.00039	0.00168	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—colon cancer	0.000388	0.144	CrCbGaD
Fluticasone Propionate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000388	0.00661	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Irinotecan—colon cancer	0.000386	0.00166	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—colon cancer	0.000384	0.00165	CcSEcCtD
Fluticasone Propionate—Dizziness—Fluorouracil—colon cancer	0.000384	0.00165	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—colon cancer	0.000383	0.00165	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000383	0.00653	CbGpPWpGaD
Fluticasone Propionate—Rash—Irinotecan—colon cancer	0.000382	0.00164	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—HNF4A—colon cancer	0.000382	0.00652	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGS2—colon cancer	0.000382	0.00651	CbGpPWpGaD
Fluticasone Propionate—Dermatitis—Irinotecan—colon cancer	0.000382	0.00164	CcSEcCtD
Fluticasone Propionate—Headache—Irinotecan—colon cancer	0.00038	0.00163	CcSEcCtD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—MYC—colon cancer	0.000377	0.00643	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—SRC—colon cancer	0.000377	0.00643	CbGpPWpGaD
Fluticasone Propionate—Mental disorder—Methotrexate—colon cancer	0.000373	0.0016	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—colon cancer	0.00037	0.00159	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—colon cancer	0.00037	0.00159	CcSEcCtD
Fluticasone Propionate—Nausea—Vincristine—colon cancer	0.00037	0.00159	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00037	0.00159	CcSEcCtD
Fluticasone Propionate—Vomiting—Fluorouracil—colon cancer	0.000369	0.00159	CcSEcCtD
Fluticasone Propionate—Rash—Fluorouracil—colon cancer	0.000366	0.00157	CcSEcCtD
Fluticasone Propionate—Dermatitis—Fluorouracil—colon cancer	0.000366	0.00157	CcSEcCtD
Fluticasone Propionate—Headache—Fluorouracil—colon cancer	0.000364	0.00156	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Capecitabine—colon cancer	0.000362	0.00155	CcSEcCtD
Fluticasone Propionate—Nausea—Irinotecan—colon cancer	0.00036	0.00155	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—colon cancer	0.000349	0.0015	CcSEcCtD
Fluticasone Propionate—Pain—Capecitabine—colon cancer	0.000347	0.00149	CcSEcCtD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.000347	0.00591	CbGpPWpGaD
Fluticasone Propionate—Nausea—Fluorouracil—colon cancer	0.000345	0.00148	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—colon cancer	0.000343	0.00148	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.000338	0.00577	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Capecitabine—colon cancer	0.000334	0.00144	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—colon cancer	0.000334	0.00143	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Capecitabine—colon cancer	0.000332	0.00143	CcSEcCtD
Fluticasone Propionate—Betamethasone—ABCB1—colon cancer	0.00033	0.123	CrCbGaD
Fluticasone Propionate—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000326	0.00556	CbGpPWpGaD
Fluticasone Propionate—Cough—Methotrexate—colon cancer	0.000323	0.00139	CcSEcCtD
Fluticasone Propionate—Urticaria—Capecitabine—colon cancer	0.000322	0.00138	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Capecitabine—colon cancer	0.000321	0.00138	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Capecitabine—colon cancer	0.000321	0.00138	CcSEcCtD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000319	0.00544	CbGpPWpGaD
Fluticasone Propionate—Arthralgia—Methotrexate—colon cancer	0.000315	0.00135	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—colon cancer	0.000315	0.00135	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—BAX—colon cancer	0.000315	0.00536	CbGpPWpGaD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000313	0.00134	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—colon cancer	0.000311	0.00134	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000306	0.00522	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000303	0.00516	CbGpPWpGaD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—colon cancer	0.000302	0.0013	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—colon cancer	0.0003	0.00129	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Capecitabine—colon cancer	0.000299	0.00128	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—colon cancer	0.000296	0.00127	CcSEcCtD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—colon cancer	0.000296	0.00505	CbGpPWpGaD
Fluticasone Propionate—Skin disorder—Methotrexate—colon cancer	0.000293	0.00126	CcSEcCtD
Fluticasone Propionate—Pruritus—Capecitabine—colon cancer	0.000287	0.00123	CcSEcCtD
Fluticasone Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.000286	0.00488	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—CASP3—colon cancer	0.000284	0.00484	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—APC—colon cancer	0.000278	0.00475	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000278	0.00474	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Capecitabine—colon cancer	0.000278	0.00119	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism—CA7—colon cancer	0.000278	0.00473	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—FGFR3—colon cancer	0.000276	0.0047	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000275	0.00118	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—colon cancer	0.000269	0.00116	CcSEcCtD
Fluticasone Propionate—Dizziness—Capecitabine—colon cancer	0.000268	0.00115	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—HRAS—colon cancer	0.000265	0.00452	CbGpPWpGaD
Fluticasone Propionate—Pain—Methotrexate—colon cancer	0.000258	0.00111	CcSEcCtD
Fluticasone Propionate—Vomiting—Capecitabine—colon cancer	0.000258	0.00111	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Endothelins—SRC—colon cancer	0.000257	0.00438	CbGpPWpGaD
Fluticasone Propionate—Rash—Capecitabine—colon cancer	0.000256	0.0011	CcSEcCtD
Fluticasone Propionate—Dermatitis—Capecitabine—colon cancer	0.000256	0.0011	CcSEcCtD
Fluticasone Propionate—Headache—Capecitabine—colon cancer	0.000254	0.00109	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—colon cancer	0.000249	0.00107	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—SRC—colon cancer	0.000247	0.00422	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—colon cancer	0.000247	0.00106	CcSEcCtD
Fluticasone Propionate—Nausea—Capecitabine—colon cancer	0.000241	0.00104	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—colon cancer	0.00024	0.00103	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000239	0.00407	CbGpPWpGaD
Fluticasone Propionate—Abdominal pain—Methotrexate—colon cancer	0.000239	0.00103	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—colon cancer	0.000239	0.00103	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000235	0.004	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000234	0.00398	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—HNF4A—colon cancer	0.000233	0.00397	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—BRAF—colon cancer	0.000227	0.00387	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000227	0.00387	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000226	0.00385	CbGpPWpGaD
Fluticasone Propionate—Dexamethasone—PTGS2—colon cancer	0.000226	0.084	CrCbGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000223	0.00379	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Methotrexate—colon cancer	0.000223	0.000956	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—EGFR—colon cancer	0.000217	0.0037	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.000215	0.00366	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Methotrexate—colon cancer	0.000214	0.000918	CcSEcCtD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.000209	0.00356	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Circadian Clock—EP300—colon cancer	0.000208	0.00355	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Methotrexate—colon cancer	0.000207	0.000888	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—colon cancer	0.000201	0.00342	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Methotrexate—colon cancer	0.0002	0.000858	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metabolism—CA7—colon cancer	0.000193	0.0033	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Methotrexate—colon cancer	0.000192	0.000825	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCB1—colon cancer	0.000192	0.0714	CrCbGaD
Fluticasone Propionate—Rash—Methotrexate—colon cancer	0.000191	0.000818	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—colon cancer	0.00019	0.000817	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—colon cancer	0.000189	0.000813	CcSEcCtD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	0.000189	0.00322	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	0.000187	0.00318	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—colon cancer	0.000186	0.00316	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000185	0.00315	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—HNF4A—colon cancer	0.000184	0.00314	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—DLC1—colon cancer	0.000183	0.00312	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—HRAS—colon cancer	0.000181	0.00308	CbGpPWpGaD
Fluticasone Propionate—Nausea—Methotrexate—colon cancer	0.000179	0.000771	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000172	0.00294	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LGR5—colon cancer	0.000172	0.00293	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—EP300—colon cancer	0.000172	0.00293	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ODC1—colon cancer	0.000168	0.00287	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CHST5—colon cancer	0.000168	0.00287	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—CDKN1A—colon cancer	0.000168	0.00286	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—PPARG—colon cancer	0.000166	0.00283	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—colon cancer	0.000164	0.00279	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000161	0.00274	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—PPARG—colon cancer	0.00016	0.00273	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—AKT1—colon cancer	0.00016	0.00272	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.000159	0.00271	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000155	0.00264	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—AKT1—colon cancer	0.000154	0.00262	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000153	0.00261	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	0.000153	0.00261	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	0.000151	0.00258	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000151	0.00257	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MYC—colon cancer	0.00015	0.00255	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—DLC1—colon cancer	0.00015	0.00255	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—NRAS—colon cancer	0.00015	0.00255	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	0.000149	0.00255	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—SRC—colon cancer	0.000148	0.00253	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—NRAS—colon cancer	0.000143	0.00243	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LGR5—colon cancer	0.000141	0.0024	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA7—colon cancer	0.00014	0.00238	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—EGFR—colon cancer	0.000136	0.00232	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	0.000135	0.00229	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000133	0.00227	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MYC—colon cancer	0.000133	0.00227	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.000131	0.00223	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—KRAS—colon cancer	0.000129	0.00219	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AXIN2—colon cancer	0.000124	0.00211	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—colon cancer	0.000123	0.0021	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—KRAS—colon cancer	0.000123	0.0021	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000121	0.00207	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—PIK3CA—colon cancer	0.000118	0.00202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000118	0.00201	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ODC1—colon cancer	0.000117	0.002	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CHST5—colon cancer	0.000117	0.002	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000117	0.00199	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000114	0.00195	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—colon cancer	0.000113	0.00193	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—CTNNB1—colon cancer	0.000113	0.00192	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—HNF4A—colon cancer	0.000112	0.00191	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—CDKN1A—colon cancer	0.00011	0.00188	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—HRAS—colon cancer	0.000109	0.00186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000109	0.00185	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	0.000108	0.00185	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000106	0.0018	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—HRAS—colon cancer	0.000104	0.00178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PIK3CA—colon cancer	0.000104	0.00178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000103	0.00176	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—PPARG—colon cancer	0.000101	0.00172	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AXIN2—colon cancer	0.000101	0.00172	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000101	0.00172	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	9.74e-05	0.00166	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—AKT1—colon cancer	9.66e-05	0.00165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.48e-05	0.00162	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MYC—colon cancer	9.46e-05	0.00161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.46e-05	0.00161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—SRC—colon cancer	9.41e-05	0.0016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.27e-05	0.00158	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	9.24e-05	0.00157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—colon cancer	9.17e-05	0.00156	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	9.15e-05	0.00156	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TGFB1—colon cancer	9.1e-05	0.00155	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	9.05e-05	0.00154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.76e-05	0.00149	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	8.57e-05	0.00146	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ODC1—colon cancer	8.47e-05	0.00144	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CHST5—colon cancer	8.47e-05	0.00144	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—colon cancer	8.41e-05	0.00143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.05e-05	0.00137	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PPARG—colon cancer	7.99e-05	0.00136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.78e-05	0.00133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	7.16e-05	0.00122	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.94e-05	0.00118	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.57e-05	0.00112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA7—colon cancer	6.5e-05	0.00111	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HNF4A—colon cancer	6.48e-05	0.0011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—colon cancer	5.85e-05	0.000997	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	5.84e-05	0.000996	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—colon cancer	5.76e-05	0.000982	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.46e-05	0.000931	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—EP300—colon cancer	4.99e-05	0.00085	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—colon cancer	4.87e-05	0.00083	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SRC—colon cancer	4.85e-05	0.000827	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—colon cancer	4.73e-05	0.000805	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NRAS—colon cancer	4.67e-05	0.000795	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—colon cancer	4.56e-05	0.000777	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.54e-05	0.000774	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCB1—colon cancer	4.44e-05	0.000757	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TYMS—colon cancer	4.36e-05	0.000744	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—colon cancer	4.34e-05	0.000739	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—colon cancer	4.02e-05	0.000685	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CHST5—colon cancer	3.94e-05	0.000671	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ODC1—colon cancer	3.94e-05	0.000671	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—colon cancer	3.69e-05	0.000629	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGFR3—colon cancer	3.57e-05	0.000609	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—colon cancer	3.57e-05	0.000609	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—colon cancer	3.41e-05	0.000582	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.36e-05	0.000573	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—colon cancer	3.33e-05	0.000568	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—colon cancer	3.28e-05	0.000559	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—colon cancer	3.16e-05	0.000539	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—colon cancer	3.1e-05	0.000528	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—colon cancer	3.09e-05	0.000527	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—colon cancer	3.08e-05	0.000525	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMS—colon cancer	3.04e-05	0.000518	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—colon cancer	3.01e-05	0.000514	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR3—colon cancer	2.92e-05	0.000497	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—colon cancer	2.81e-05	0.000479	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—colon cancer	2.77e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—colon cancer	2.68e-05	0.000457	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—colon cancer	2.68e-05	0.000457	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—colon cancer	2.52e-05	0.000429	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—colon cancer	2.44e-05	0.000416	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—colon cancer	2.43e-05	0.000415	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—colon cancer	2.31e-05	0.000394	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—colon cancer	2.31e-05	0.000393	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—colon cancer	2.25e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—colon cancer	2.24e-05	0.000382	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—colon cancer	2.23e-05	0.00038	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMS—colon cancer	2.2e-05	0.000375	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—colon cancer	2.18e-05	0.000371	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—colon cancer	2.15e-05	0.000367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—colon cancer	2.12e-05	0.000361	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—colon cancer	2.07e-05	0.000353	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—colon cancer	2.02e-05	0.000345	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—colon cancer	2.01e-05	0.000343	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—colon cancer	1.96e-05	0.000334	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—colon cancer	1.96e-05	0.000334	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—colon cancer	1.94e-05	0.00033	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—colon cancer	1.92e-05	0.000328	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—colon cancer	1.89e-05	0.000322	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—colon cancer	1.84e-05	0.000313	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—colon cancer	1.82e-05	0.00031	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—colon cancer	1.8e-05	0.000308	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—colon cancer	1.8e-05	0.000307	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—colon cancer	1.78e-05	0.000303	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—colon cancer	1.76e-05	0.000301	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—colon cancer	1.73e-05	0.000295	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—colon cancer	1.69e-05	0.000289	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—colon cancer	1.69e-05	0.000288	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—colon cancer	1.67e-05	0.000284	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—colon cancer	1.64e-05	0.00028	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—colon cancer	1.6e-05	0.000273	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—colon cancer	1.6e-05	0.000273	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—colon cancer	1.58e-05	0.00027	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—colon cancer	1.56e-05	0.000265	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—colon cancer	1.53e-05	0.000261	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—colon cancer	1.5e-05	0.000255	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—colon cancer	1.48e-05	0.000253	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—colon cancer	1.47e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—colon cancer	1.47e-05	0.000251	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—colon cancer	1.44e-05	0.000246	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—colon cancer	1.42e-05	0.000242	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—colon cancer	1.41e-05	0.00024	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—colon cancer	1.36e-05	0.000232	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—colon cancer	1.25e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—colon cancer	1.25e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—colon cancer	1.23e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—colon cancer	1.22e-05	0.000208	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—colon cancer	1.21e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—colon cancer	1.16e-05	0.000197	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—colon cancer	1.11e-05	0.00019	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—colon cancer	1.04e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—colon cancer	1.04e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMS—colon cancer	1.02e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—colon cancer	1.02e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—colon cancer	1.02e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—colon cancer	8.52e-06	0.000145	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—colon cancer	7.54e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—colon cancer	7.24e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—colon cancer	6.16e-06	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—colon cancer	5.7e-06	9.71e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—colon cancer	4.74e-06	8.07e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—colon cancer	3.5e-06	5.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—colon cancer	2.86e-06	4.88e-05	CbGpPWpGaD
